Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9518118 Anti-HER2 antibodies and immunoconjugates

Patent 9518118 was granted and assigned to Genentech on December, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

95181180

Patent Inventor Names

Gail Lewis Phillips0

Jagath Reddy Junutula0

Mark Dennis0

Mark X. Sliwkowski0

Thomas Harden Pillow0

Xiaocheng Chen0

Date of Patent

December 13, 2016

Patent Application Number

148510010

Date Filed

September 11, 2015

Patent Citations Received

‌

US Patent 11883432 Chimeric antigen receptor system with adaptable receptor specificity

‌

US Patent 11938194 Cysteine mutated antibodies for conjugation

‌

US Patent 11873330 Cysteine engineered antibodies and conjugates

Patent Primary Examiner

‌

Brad Duffy

Patent abstract

The invention provides anti-HER2 antibodies and immunoconjugates and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9518118 Anti-HER2 antibodies and immunoconjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API